To investigate the relationship between the FX-mediated suppression of tumor development and ferroptosis, we conducted an immunohistochemistry (IHC) analysis to assess the expression of vital ferroptosis-associated targets, including SLC7A11 and GPX4 in tumor tissues (Figure 8E). The gene discussed is SLC7A11; the disease is neoplasm.